FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. The approval involves a supplemental submission to update the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• APLENZIN (BUPROPION HYDROBROMIDE)

Snippet

SUPPL AP for APLENZIN (BUPROPION HYDROBROMIDE)